This Core Support Center Grant (P30) application requests continued support for an analytical and synthetic chemistry laboratory and administrative core infrastructure. The currently funded constituent projects continue research programs with human laboratory and treatment clinic studies of the clinical pharmacology of abused drugs, pharmacotherapies and other treatment strategies to treat drug abuse and addictions. Disciplines represented by the participating projects and investigators include psychiatry, clinical psychology, general internal medicine and clinical pharmacology, cardiology, pulmonary medicine, pediatrics, and chemistry. Currently, the supported projects involve primarily the problems associated with tobacco addiction, but we are prepared to support studies of other abused drugs as well.
Our aims are: (1) To provide a state-of-the-art, well equipped and staffed, analytical and synthetic chemistry laboratory resource for the participating projects of drug abuse researchers at UCSF and at other institutions. (2) To provide consultation regarding optimal study design and data analysis strategies, particularly regarding pharmacokinetic analysis for participating projects. The overall objective is to provide sophisticated analytical laboratory resources responsive to the needs of individual constituent scientific projects as these projects change and evolve. This facility is a cost-effective shared laboratory resource that enhances research possibilities to further our understanding of human psychoactive drug use, abuse and addiction, its health consequences and its treatment.

Public Health Relevance

Tobacco and other abused drugs cause tens of thousands of premature deaths annually in the US, and are responsible for much human suffering. The research projects that our P30 Center supports seek to reduce this human toll, by understanding the factors that cause drug addiction, in order to develop more effective treatments and prevention programs. Since tobacco smoking releases potent toxic substances, some of the projects supported by our Center are studying contamination by secondhand smoke, in order to assess exposure of nonsmokers to these toxic substances, and guide public policy to reduce these exposures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA012393-20
Application #
9716578
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Kline, Richard
Project Start
1999-09-01
Project End
2020-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
20
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Psychiatry
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Pulvers, Kim; Emami, Ashley S; Nollen, Nicole L et al. (2018) Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes. Nicotine Tob Res 20:206-214
Panzer, Ariane R; Lynch, Susan V; Langelier, Chaz et al. (2018) Lung Microbiota Is Related to Smoking Status and to Development of Acute Respiratory Distress Syndrome in Critically Ill Trauma Patients. Am J Respir Crit Care Med 197:621-631
Benowitz, Neal L; Flanagan, Christie A; Thomas, Timothy K et al. (2018) Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users. Int J Circumpolar Health 77:1528125
Vogel, Erin A; Ramo, Danielle E; Rubinstein, Mark L (2018) Prevalence and correlates of adolescents' e-cigarette use frequency and dependence. Drug Alcohol Depend 188:109-112
Rubinstein, Mark L; Delucchi, Kevin; Benowitz, Neal L et al. (2018) Adolescent Exposure to Toxic Volatile Organic Chemicals From E-Cigarettes. Pediatrics 141:
Benowitz, Neal L; Nardone, Natalie; Jain, Shonul et al. (2018) Comparison of Urine 4-(Methylnitrosamino)-1-(3)Pyridyl-1-Butanol and Cotinine for Assessment of Active and Passive Smoke Exposure in Urban Adolescents. Cancer Epidemiol Biomarkers Prev 27:254-261
St Helen, Gideon; Shahid, Marian; Chu, Sherman et al. (2018) Impact of e-liquid flavors on e-cigarette vaping behavior. Drug Alcohol Depend 189:42-48
Nabavizadeh, Pooneh; Liu, Jiangtao; Havel, Christopher M et al. (2018) Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob Control 27:s13-s19
St Helen, Gideon; Jacob Iii, Peyton; Nardone, Natalie et al. (2018) IQOS: examination of Philip Morris International's claim of reduced exposure. Tob Control 27:s30-s36
Hang, Bo; Snijders, Antoine M; Huang, Yurong et al. (2017) Early exposure to thirdhand cigarette smoke affects body mass and the development of immunity in mice. Sci Rep 7:41915

Showing the most recent 10 out of 187 publications